Skip Nav Destination
Issues
1 September 1997
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Issue Sections
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Articles
Analysis of the FHIT Gene and FRA3B Region in Sporadic Breast Cancer, Preneoplastic Lesions, and Familial Breast Cancer Probands1
Mohsen Ahmadian; Ignacio I. Wistuba; Kwun M. Fong; Carmen Behrens; Dulmini R. Kodagoda; M. Hossein Saboorian; Jerry Shay; Gail E. Tomlinson; Joanne Blum; John D. Minna; Adi F. Gazdar
Inhibitors of Epidermal Growth Factor Receptor Kinase and of Cyclin-dependent Kinase 2 Activation Induce Growth Arrest, Differentiation, and Apoptosis of Human Papilloma Virus 16-immortalized Human Keratinocytes1
Hannah Ben-Bassat; Stella Rosenbaum-Mitrani; Zippora Hartzstark; Zippora Shlomai; Nurit Kleinberger-Doron; Aviv Gazit; Gregory Plowman; Rubina Levitzki; Rimona Tsvieli; Alexander Levitzki
Genomic DNA-based hMSH2 and hMLH1 Mutation Screening in 32 Eastern United States Hereditary Nonpolyposis Colorectal Cancer Pedigrees1
Thomas K. Weber; Wendy Conlon; Nicholas J. Petrelli; Miguel Rodriguez-Bigas; Bernadette Keitz; James Pazik; Carolyn Farrell; Linda O'Malley; Maximillian Oshalim; May Abdo; Garth Anderson; Daniel Stoler; David Yandell
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.